Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
GlaxoSmithKline
GlaxoSmithKline
Ocellaris Pharma, Inc.
Young Adult Survivors United
Adaptimmune
Adaptimmune
Sumitomo Pharma America, Inc.
Theseus Pharmaceuticals
University of Virginia
NBE-Therapeutics AG
Children's National Research Institute
Aristotle University Of Thessaloniki
Gradalis, Inc.
Bristol-Myers Squibb
University Hospital, Lille
Swiss Cancer Institute
Pfizer
InSightec
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Lexent Bio, Inc.
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Balgrist University Hospital
Merck Sharp & Dohme LLC
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)
The Cleveland Clinic
Masonic Cancer Center, University of Minnesota
Centre Leon Berard
University of South Florida